Off-brand versions of Lilly weight loss drug must be pulled off market, could mean higher prices
The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved and that specialty pharmacies and online companies need to stop selling off-brand versions of the weight-loss drugs. The FDA has issued warnings against the off-brand versions, citing safety concerns.
Shares of Eli Lilly & Co. LLY sank 0.08% to $795.67 Tuesday, on what proved to be an all-around favorable trading session for ...
Eli Lilly's obesity drug Mounjaro will be available through Britain's state health system for some patients from March, after ...
Lilly investors got the jitters, saw better opportunities elsewhere, or decided to hold onto their chips. In the third ...
The Olympian (TCA) on MSN20h
Here’s why there was a large police response on Lilly Road in Olympia Saturday morningA 31-year-old man was arrested on suspicion of multiple crimes Saturday morning after police say he assaulted his wife, ...
Since pharmaceutical giant Eli Lilly (NYSE: LLY) reported earnings for the third quarter on Oct. 30, shares have been ...
The mega-blockbuster weight loss GLP-1 drug is now also approved to treat obstructive sleep apnea in adults with obesity, in ...
Eli Lilly and Company (NYSE: LLY) shares are trading higher Monday. The upward momentum in the stock comes after the FDA ...
The deal will open the door for the company to tap into an archive of more than 2,000 designs by Key West Hand Print Fabrics ...
Twins Sophie and Lilly Phillips are still close, but have forged their own paths playing Division I basketball at different ...
The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe ...
Eli Lilly said the Food and Drug Administration approved Zepbound for moderate-to-severe obstructive sleep apnea in adults ...
We recently compiled a list of the Jim Cramer Discusses 17 Stocks And Blasts Zero Day Options. In this article, we are going ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback